Development of a comprehensive in silico platform for the prediction and analysis of protein - noble gas interactions and potential therapeutic applications across the entire human proteome.
The project is aiming at developing an innovative gallium-based pet imaging technology, whose final application is a radiopharmaceutical allowing a better diagnosis of cancer when fdg lacks efficacy or sensitivity.
The catiomerc project aims to develop 100% natural cationic bio-charges for industrial applications in the field of cosmetic as an alternative to conventional petrochemical surfactants. These bio-charges are from the alliance of a section of chitin and / or its derivatives and clay.
Nanospeed and concile are committed to develop and commercialise true proprietary point-of-care-test (poct) platforms that will allow the user (healthcare practitioner) to have quick and accurate access to crucial 'personal health information' such as: vitamine d, and ferritin.
The project will address the urgent need for new drugs to effectively combat infections caused by flaviviruses such as zika or dengue virus through blocking a protein critical to their lifecycle using innovative macrocyclic chemistry.
This project will develop the omegaspot(tm) which is a rapid, point-of-care (poc) diagnostic test that semi quantitatively determines user's levels of the omega-3 fatty acid docosahexaenoic acid (dha) from drops of blood.